Resectable Intrahepatic Cholangiocarcinoma Clinical Trials in Pittsburgh, Pennsylvania

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery